NASDAQ:IONS
Ionis Pharmaceuticals, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Selectwebsite
www.ionispharma.comipo date
May 17, 1991full time employees
796currency
USD
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus